Impact of intramuscular adipose tissue content on short- and long-term outcomes of hepatectomy for colorectal liver metastasis: a retrospective analysis

[1] Dodson S(2011)Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies Annu Rev Med 62 265-279

[2] Baracos VE(2012)Muscles, exercise and obesity: skeletal muscle as a secretory organ Nat Rev Endocrinol 8 457-465

[3] Jatoi A(2015)Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery Ann Surg Oncol 22 4445-4452

[4] Evans WJ(2017)Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer Eur J Surg Oncol 43 478-484

[5] Cella D(2016)Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients J Cachexia Sarcopenia Muscle 7 458-466

[6] Dalton JT(2016)Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort Medicine (Baltimore) 95 e3164-775

[7] Pedersen BK(2014)Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma J Surg Oncol 111 771-635

[8] Febbraio MA(2008)Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 9 629-1419

[9] Reisinger KW(2014)Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation Liver Transpl 20 1413-1514

[10] Bosmans JW(2013)Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle J Gastroenterol Hepatol 28 1507-574

[1] Dodson S(2011)Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies Annu Rev Med 62 265-279

[2] Baracos VE(2012)Muscles, exercise and obesity: skeletal muscle as a secretory organ Nat Rev Endocrinol 8 457-465

[3] Jatoi A(2015)Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery Ann Surg Oncol 22 4445-4452

[4] Evans WJ(2017)Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer Eur J Surg Oncol 43 478-484

[5] Cella D(2016)Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients J Cachexia Sarcopenia Muscle 7 458-466

[6] Dalton JT(2016)Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort Medicine (Baltimore) 95 e3164-775

[7] Pedersen BK(2014)Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma J Surg Oncol 111 771-635

[8] Febbraio MA(2008)Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 9 629-1419

[9] Reisinger KW(2014)Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation Liver Transpl 20 1413-1514

[10] Bosmans JW(2013)Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle J Gastroenterol Hepatol 28 1507-574